Teva Pharmaceutical Industries
TEVA
#541
Rank
ยฃ34.34 B
Marketcap
ยฃ29.44
Share price
-8.74%
Change (1 day)
57.33%
Change (1 year)

P/S ratio for Teva Pharmaceutical Industries (TEVA)

P/S ratio as of November 2026 (TTM): 2.61

According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.80. At the end of 2026 the company had a P/S ratio of 2.68.

P/S ratio history for Teva Pharmaceutical Industries from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.6830.06%
20252.0631.94%
20241.56108.57%
20230.747710.16%
20220.678721.97%
20210.5564-10.99%
20200.6251-4.94%
20190.6576-26.92%
20180.89984.81%
20170.8585-48.89%
20161.68-44.21%
20153.0125.69%
20142.4044.02%
20131.666.12%
20121.57-19.45%
20111.95-32.94%
20102.90-18.91%
20093.584.86%
20083.41-14.5%
20073.9936.19%
20062.93-44.67%
20055.3035.81%
20043.90-18.84%
20034.8121.21%
20023.974.34%
20013.80

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
4.98 90.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.47-5.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.89-27.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
4.86 86.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.36 67.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.15-17.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
3.50 34.16%๐Ÿ‡ฎ๐Ÿ‡ณ India